Summary of Results of ECOG Clinical Trials
To help patients learn the results of the trials in which they may
have participated or to understand the science that has been conducted
for a particular cancer, the Eastern Cooperative Oncology Group (ECOG)
summarizes the results of its published trials beginning with those
published in 2004. Search by protocol number, disease site, or drug
name, in order to find the results of earlier research.
Click here to jump to summary list and Search
ECOG is indebted to thousands of cancer patients, research scientists,
physicians, patient advocates, and other healthcare and scientific
professionals for the successful completion of hundreds of trials
since its inception in 1955.
For research information about the results of clinical trials
published prior to 2004, visit the following links:
NCI Clinical Trial Results by Type of Cancer or
Topic (on NCI web site)
PubMed (on NCBI web site)
Clinical trial results for many marketed
pharmaceuticals (on ClinicalStudyResults web site)
You can also search the Web sites of the major pharmaceutical
companies to find the results of cancer clinical trials.
Search ECOG Trial Results Summaries
AIDS Working Group
- E1494 PhII Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide + Didanosine & G-CSF in Patients with HIV-Rel Intermediate & High-Grade NHL
Biologic Response Modifiers
- E7897 Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer
Brain Tumor Working Group
- E6397 Phase II Trial of Radiosurgery for 1 to 3 Newly Diagnosed Brain Metastases from Renal Cell, Melanoma, and Sarcoma
Breast
- E2196 A Randomized Phase III Trial of Marimastat Vs. Placebo in Patients with Metastatic Breast Cancer Who Have Responding or Stable Disease after Induction Chemotherapy.
GYN Working Group
- E1E96 Phase II Clinical Trial of Interleukin-12 in Patients with Advanced, Recurrent or Inoperable Carcinoma of the Cervix
- E9501 Phase II Study of 9-20-S-Amino-Camptothecin (9-AC) as Second Line Therapy in Advanced Ovarian Carcinoma - Intergroup
Gastrointestinal
- E8293 Phase III Study of Radiation Therapy, Levamisole and 5-FU vs 5-FU and Levamisole in Selected Patients With Completely Resected Colon Cancer
- E8296 Phase II Adjuvant Chemotherapy for Resected Adenocarcinoma of the Esophagus, G-E Junction and Cardia
- E9292 Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors
Genitourinary
- E4897 Phase III Trial of MVAC vs Carboplatin and Paclitaxel in Advanced Carcinoma of the Urothelium
Head and Neck
- E3395 Phase II Evaluation of 96 Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck.
Leukemia
- E1488 Phase II Trial of Pentostatin with Chlorambucil and Prednisone in Patients with Chronic Lymphocytic Leukemia
- E2995 Phase III Randomized Trial Comparing MEC Chemotherapy with MEC Plus PSC 833 (PSC-MEC) in Patients with Relapsed and Refractory AML
- E3993 Phase III Study Priming with rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and over) with Acute Non-Lymphocytic Leukemia
- E4998 Phase II Study of Theophylline in Chronic Lymphocytic Leukemia
Lymphoma
- E1484 Phase III Randomized Trial of Chemo vs. Chemo + RTConsolidation in Unfavourable Non-Hodgkin's Lymphoma
Melanoma
- E1673 Immunotherapy Using BCG given by Multiple PunctureTechnic in Patients with 'Early' Melanoma
Myeloma
- E4A97 A phase II study of high-dose melphalan With hematopoietic stem cell reconstitution for patients with primary systemic amyloidosis
Thoracic
- E1C97 A Phase II Study of Octreotide Treatment of Advanced, Recurrent Thymoma
- E2595 Phase II Study of Taxotere for Malignant Mesothelioma
- E2598 Phase II Pilot Trial of Carboplatin, Paclitaxel and Herceptin in HER2/neu (+) Advanced Non Small Cell Lung Cancer
Return to ECOG Home Page
How to contact ECOG
All contents copyright © 2006 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: Daily